Difference between revisions of "C1 inhibitor"
| Line 23: | Line 23: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | Q453 | + | | [[TG2 reactive residues (C1 inhibitor)|Q453]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 33: | Line 33: | ||
|- | |- | ||
| Structure | | Structure | ||
| − | | | + | | [[http://www.pdb.org/pdb/explore.do?structureId=2OAY 2OAY]] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
Revision as of 07:26, 3 September 2007
| Template:Infobox header| C1 inhibitor | |
|---|---|
| C1 inhibitor | |
| Substrate peptide name | C1 inhibitor |
| Synonyms | C1 esterase inhibitor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P05155 |
| Reactive glutamines | Q453 |
| Reactive lysines | - |
| Substrate sequence | VFEVQQPFLFV |
| Structure | [2OAY] |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10799541 |
| Notes | TG2 action does not influence the protein's function |
| Template:Infobox header | | |
